Small EVs from ECs with Krüppel-like factor 2 (KLF2) overexpression can be used as a treatment against DCM-HF; KLF2 exerts an anti-inflammatory effect, ameliorating left ventricular dysfunction in DCM mice. Here, KLF2 is linked to familial dilated cardiomyopathy.